Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN106188113B details water-soluble BODIPY synthesis. Offers improved purity and supply chain stability for pharmaceutical intermediate manufacturing processes.
Patent CN114249668B reveals safer PPTS catalysis for Zolpidem intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel patent CN109280055A enables scalable ergot alkaloid production. Reduced steps and enhanced chirality control for reliable pharmaceutical intermediate supply chains.
Patent CN102584509A reveals a green iodide-catalyzed amide synthesis. Discover cost-effective manufacturing solutions for high-purity pharmaceutical intermediates.
Patent CN113185465A reveals a high-yield Stille coupling route for 4-ethyl-5-aminopyrimidine, offering significant cost reduction in pharmaceutical intermediate manufacturing through mild conditions.
Novel 8-step synthetic route for Loxoprofen Sodium from p-methylacetophenone. High yield, solvent recovery, and scalable NSAID intermediate manufacturing technology.
Novel cyclopropanation method using diethylzinc and diiodomethane offers high yields and mild conditions for scalable API intermediate manufacturing.
Novel cobalt-catalyzed CO2 carboxylation patent offers cost-effective route for high-purity isonicotinic acid intermediates, enhancing supply chain reliability for global pharma manufacturing.
Patent CN102659705A reveals a novel base-mediated route for 3,4-disubstituted isoxazoles, offering high yields and simplified supply chains for drug manufacturing.
Patent CN103864878A reveals a novel cross-coupling method for Abiraterone Acetate using organozinc reagents, offering significant cost reduction and improved purity for pharmaceutical intermediates manufacturing.
Patent CN116655503B reveals catalyst-free synthesis for high-purity pharmaceutical intermediates. Achieve cost reduction and supply chain reliability with scalable methods.
Patent CN107935912B reveals a safer, non-NaH route for Amlodipine intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN108299302A details a novel 3-step synthesis for 3-acetylpyrazole, offering safer operations and scalable production for global pharmaceutical supply chains.
Discover a novel selenium-catalyzed method for propargyl alpha-amino boronate synthesis. Offers mild conditions, broad substrate scope, and cost-effective manufacturing for pharmaceutical intermediates.
Advanced water-based synthesis for 1,2,3-triazoles offers significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturing partners.
Patent CN116003312B reveals a metal-free boron catalysis method for meta-selective pyridine functionalization, offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112479876B details a novel chiral resolution method for oxazepane spiro compounds, offering improved stereoselectivity and streamlined manufacturing for global supply chains.
Novel preparation method for Tezacaftor via reductive cyclization. High purity, low cost, scalable industrial process for API intermediates.
Patent CN116589519A reveals improved sulfonation and Suzuki coupling for high-purity API intermediate manufacturing with reduced corrosion risks and enhanced scalability.
Novel zinc-mediated route for Vilazodone intermediate. High yield, low waste, scalable production for pharma supply chains ensuring reliability and cost efficiency globally for all buyers.